MDxHealth
MDXH
7 hedge funds and large institutions have $29.1M invested in MDxHealth in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
19.66% more ownership
Funds ownership: 0% → 19.66% (+20%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$19.2M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$882K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$434K |
| 4 |
ACM
Altium Capital Management
New York
|
+$354K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$196K |
Top Sellers
MDXH Hedge Fund Activity: Q4 2021 in Review
7 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q4 2021, worth a combined $29.1M.
Buyers outnumbered sellers: 7 funds opened new MDXH positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bleichroeder LP, opening a new position worth an estimated $19.2M.
- 7 institutional investors held MDxHealth (MDXH) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $29.1M of MDxHealth stock for Q4 2021.
- 7 funds opened new MDxHealth positions in Q4 2021 and 0 closed out, a net change of +7 holders.
- The largest MDxHealth buyer in Q4 2021 was Bleichroeder LP, an estimated $19.2M added.
Based on aggregated 13F filings for Q4 2021.